|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.47 INR | +1.38% |
|
+7.05% | -27.68% |
| Market Cap | 976M 10.23M 8.87M 8.3M 7.57M 14.25M 14.49M 97.33M 38.13M 488M 38.42M 37.58M 1.63B | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 14.09M 12.21M 11.43M 10.43M 19.63M 19.96M 134M 52.53M 673M 52.91M 51.76M 2.24B | EV / Sales 2024 |
12,382,225x | EV / Sales 2025 | 14,298,457x |
| Free-Float |
25.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.38% | ||
| 1 week | +7.05% | ||
| Current month | +11.19% | ||
| 1 month | +1.23% | ||
| 3 months | +15.21% | ||
| 6 months | -13.54% | ||
| Current year | -27.68% |
| 1 week | 32.99 |  | 36.3 |
| 1 month | 29.12 | | 36.9 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 66 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.38% | +7.05% | -46.06% | +8.43% | 12.57M | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.11% | +0.25% | +48.38% | +38.04% | 363B | |
| -1.22% | +0.21% | +29.61% | +37.18% | 295B | |
| -0.92% | -2.40% | +5.96% | +5.69% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| -2.13% | +2.23% | -6.13% | -51.42% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -0.40% | +1,499.99% | +25.64% | +40.92% | 365.91B | |
| Weighted average by Cap. | -0.78% | +1,332.61% | +49.20% | +65.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.58 1.37 1.29 1.17 2.21 2.24 15.07 5.91 75.64 5.95 5.82 252.35 | 195.14 2.05 1.77 1.66 1.51 2.85 2.9 19.46 7.63 97.67 7.68 7.51 325.85 |
| Net income | -79.68M -835K -724K -678K -618K -1.16M -1.18M -7.95M -3.11M -39.88M -3.14M -3.07M -133M | -108M -1.13M -979K -917K -836K -1.57M -1.6M -10.75M -4.21M -53.94M -4.24M -4.15M -180M |
| Net Debt | 37.29M 391K 339K 317K 289K 545K 554K 3.72M 1.46M 18.66M 1.47M 1.44M 62.27M | 368M 3.86M 3.35M 3.13M 2.86M 5.38M 5.47M 36.73M 14.39M 184M 14.5M 14.18M 615M |
Employees
28
Sector
Pharmaceuticals
Calendar
02:45pm
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | ₹34.47 | +1.38% | 2,692 |
| 11/08/26 | ₹34.00 | -2.94% | 19,203 |
| 10/08/26 | ₹35.03 | +1.54% | 13,937 |
| 07/08/26 | ₹34.50 | -2.82% | 10,336 |
| 06/08/26 | ₹35.50 | +10.25% | 54,155 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
